parkin mutation dosage and the phenomenon of anticipation: a molecular genetic study of familial parkinsonism

dc.contributor.authorPoorkaj, Parvonehen_US
dc.contributor.authorMoses, Linaen_US
dc.contributor.authorMontimurro, Jennifer S.en_US
dc.contributor.authorNutt, John G.en_US
dc.contributor.authorSchellenberg, Gerard D.en_US
dc.contributor.authorPayami, Haydehen_US
dc.date.accessioned2010-05-06T20:03:28Z
dc.date.available2010-05-06T20:03:28Z
dc.date.issued2005en_US
dc.description.abstractBackground: parkin mutations are a common cause of parkinsonism. Possessing two parkin mutations leads to early-onset parkinsonism, while having one mutation may predispose to lateonset disease. This dosage pattern suggests that some parkin families should exhibit intergenerational variation in age at onset resembling anticipation. A subset of familial PD exhibits anticipation, the cause of which is unknown. The aim of this study was to determine if anticipation was due to parkin mutation dosage. Methods: We studied 19 kindreds that had early-onset parkinsonism in the offspring generation, late-onset parkinsonism in the parent generation, and = 20 years of anticipation. We also studied 28 early-onset parkinsonism cases without anticipation. Patients were diagnosed by neurologists at a movement disorder clinic. parkin analysis included sequencing and dosage analysis of all 12 exons. Results: Only one of 19 cases had compound parkin mutations, but contrary to our postulate, the affected relative with late-onset parkinsonism did not have a parkin mutation. In effect, none of the anticipation cases could be attributed to parkin. In contrast, 21% of early-onset parkinsonism patients without anticipation had parkin mutations. Conclusion: Anticipation is not linked to parkin, and may signify a distinct disease entity.en_US
dc.description.sponsorshipFinancial support was provided by grants from the National Institutes of Health (RO1 NS36960) and the Veterans' Administration (PADRECC).en_US
dc.identifier.citationPoorkaj P, Moses L, Montimurro J, et al. parkin mutation dosage and the phenomenon of anticipation: a molecular genetic study of familial parkinsonism. BMC Neurology. 2005;5(1):4.en_US
dc.identifier.other10.1186/1471-2377-5-4en_US
dc.identifier.urihttp://www.biomedcentral.com/1471-2377/5/4en_US
dc.identifier.urihttp://hdl.handle.net/1773/15821
dc.language.isoen_USen_US
dc.titleparkin mutation dosage and the phenomenon of anticipation: a molecular genetic study of familial parkinsonismen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
1471-2377-5-4.pdf
Size:
231.63 KB
Format:
Adobe Portable Document Format